mdlinx mdlinx
Latest (58) Full Text Articles (1263) Focus on Eating Disorders Article Summary

Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study
International Journal of Clinical Practice,  Clinical Article

Mattarozzi K et al. – This first prospective study provides objective data showing that early disclosure of multiple sclerosis diagnosis improves both the patient's quality of life and psychological well–being. In addition, the results seem to suggest that clinically isolated syndrome disclosure does not lead to the same favourable effects.

Methods
  • Eligible participants were all patients referred for the first time to the Neurological Unit who had manifested symptoms suggestive of MS for no more than 6 months.
  • All patients were evaluated for
    • QoL (SEIQoL and MS-QoL54).
    • Anxiety (STAI) and Depression (CMDI) on study inclusion (T0), 30 days after diagnosis disclosure (T30), and after 1 (T1y) and 2 (T2y) years' follow-up.

Results
  • Two hundred and twenty-nine patients were enrolled; 93 of these were unaware of their diagnosis.
  • Patients who already knew their diagnosis (100 with CIS and 22 with MS) were excluded from the main analyses and used to perform control analyses.
  • At the end of the screening, an MS diagnosis was disclosed to 18 of the 93 patients, whereas a CIS diagnosis was disclosed to 62 patients (12 patients received a diagnosis other than MS or CIS).
  • Thirty days after diagnosis disclosure, irrespective of the diagnosis disclosed, both QoL and Anxiety and Depression were significantly rated as better compared to the start of screening, (ps < 0.03), and this improvement remained stable over the two annual follow-ups.
  • However, as suggested by a significant `Time' × `Diagnosis' interaction with regard to both QoL and Anxiety and Depression (ps < 0.02), the effect of the disclosure in the short term differed depending on CIS or MS diagnosis.
  • Specifically, on MSQoL, which is a health-related QoL scale, the authors found a statically significant improvement, immediately after the diagnosis disclosure, in both the MS and CIS groups (ps < 0.01).
  • Differently, on SEIQoL, which is a non health-related QoL measure, and on the anxiety scale, the authors observed a statistically significant improvement only in the group which received a MS diagnosis (ps < 0.03).

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Psychiatry Articles

Last month's top read Top Articles of 2013

1 Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials Psychosomatic Medicine, March 20, 2014    Evidence Based Medicine    Review Article    Clinical Article

2 Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: Randomized double-blind placebo-controlled study Journal of Psychiatric Research, March 14, 2014    Clinical Article
Exclusive Author Commentary

3 Selective serotonin reuptake inhibitor drug interactions in patients receiving statins The Journal of Clinical Psychiatry, March 5, 2014    Clinical Article

4 Salivary exoglycosidases as a markers of alcohol dependence Alcohol and Alcoholism , March 17, 2014    Clinical Article

5 Effect of reiki therapy on pain and anxiety in adults: an in-depth literature review of randomized trials with effect size calculations Pain Management Nursing, March 19, 2014    Review Article    Clinical Article

6 Cognitive effects of statin medications CNS Drugs, February 18, 2014    Clinical Article

7 A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike? International Clinical Psychopharmacology, January 15, 2014    Review Article    Clinical Article

8 Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis Schizophrenia Bulletin, March 25, 2014    Evidence Based Medicine

9 Agomelatine: A new option for treatment of depression? Expert Opinion on Pharmacotherapy, February 14, 2014    Clinical Article

10 Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol Full Text BMC Complementary and Alternative Medicine, March 12, 2014    Free full text    Clinical Article

11 Bipolar or borderline: A clinical overview Acta Psychiatrica Scandinavica, February 27, 2014    Review Article

12 Hypnotherapy is more effective than nicotine replacement therapy for smoking cessation: Results of a randomized controlled trial Complementary Therapies in Medicine, March 3, 2014    Clinical Article

13 Pregabalin in acute treatment of anxious depression: A case series Psychiatry Research, February 13, 2014    Clinical Article

14 Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: A meta-analysis Psychiatry Research, March 10, 2014    Evidence Based Medicine

15 A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia Schizophrenia Research, March 26, 2014    Clinical Article

16 Psychodynamic psychotherapy versus cognitive behavior therapy for social anxiety disorder: An efficacy and partial effectiveness trial Depression and Anxiety, February 28, 2014    Clinical Article

17 Lurasidone monotherapy in the treatment of bipolar I depression: A randomized, double-blind, placebo-controlled study American Journal of Psychiatry, February 7, 2014    Clinical Article

18 Electronic cigarette use outcome expectancies among college students Addictive Behaviours, March 11, 2014    Clinical Article

19 Gabapentin treatment for alcohol dependence: A randomized clinical trial JAMA Internal Medicine, January 10, 2014    Evidence Based Medicine    Clinical Article

20 Cannabis and psychosis: Neurobiology Full Text Indian Journal of Psychiatry, January 17, 2014    Free full text    Review Article

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore

Other Topics in Psychiatry

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow
Like

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close